Skip to content
10-Q

Quarterly Report

OCATA THERAPEUTICS, INC.

0001019687-15-001797

← back to feed
Filed
May 7, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · Apr 30, 2015 35.67M sh
Capex Q1 2015 · Mar 31, 2015 $20.43K
Capex Q1 2015 · Mar 31, 2014 $91.4K
Cash And Equivalents Q1 2015 · Mar 31, 2015 $3.53M
Cash And Equivalents Q1 2015 · Dec 31, 2014 $4.42M
Cash And Equivalents Q1 2015 · Mar 31, 2014 $4.01M
Cash And Equivalents Q1 2015 · Dec 31, 2013 $1.74M
Stockholders Equity Q1 2015 · Mar 31, 2015 −$2.09M
Stockholders Equity Q1 2015 · Dec 31, 2014 −$2.74M
Current Liabilities Q1 2015 · Mar 31, 2015 $4.21M
Current Liabilities Q1 2015 · Dec 31, 2014 $5.68M
Total Liabilities Q1 2015 · Mar 31, 2015 $6.96M
Total Liabilities Q1 2015 · Dec 31, 2014 $8.47M
Current Assets Q1 2015 · Mar 31, 2015 $3.96M
Current Assets Q1 2015 · Dec 31, 2014 $4.75M
Total Assets Q1 2015 · Mar 31, 2015 $4.88M
Total Assets Q1 2015 · Dec 31, 2014 $5.74M
Sga Expense Q1 2015 · Mar 31, 2015 $3.69M
Sga Expense Q1 2015 · Mar 31, 2014 $3.31M
Rd Expense Q1 2015 · Mar 31, 2015 $3.38M
Rd Expense Q1 2015 · Mar 31, 2014 $2.51M
Net Income Q1 2015 · Mar 31, 2015 −$7.04M
Net Income Q1 2015 · Mar 31, 2014 −$8.69M
Operating Income Q1 2015 · Mar 31, 2015 −$7.04M
Operating Income Q1 2015 · Mar 31, 2014 −$7.7M
Gross Profit Q1 2015 · Mar 31, 2015 $23.86K
Gross Profit Q1 2015 · Mar 31, 2014 $23.86K
Cost Of Revenue Q1 2015 · Mar 31, 2015 $15.61K
Cost Of Revenue Q1 2015 · Mar 31, 2014 $15.61K